title: Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma.
abstract: Melanoma has a high potential to develop metastases. Accurate staging is essential for appropriate management. Sentinel node (SN) status is a powerful prognostic factor in early stage melanoma. Staging is assisted by SN biopsy after lymphoscintigraphy to locate all true SNs prior to biopsy. PET using F18-FDG can detect metastases and is used to restage patients with AJCC Stages III and IV disease before planning surgery with curative intent.
authors.affiliation: Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. ruren@usyd.edu.au
authors.forename: Roger F
authors.initials: RF
authors.lastname: Uren
authors.forename: Robert
authors.initials: R
authors.lastname: Howman-Giles
authors.forename: David
authors.initials: D
authors.lastname: Chung
authors.forename: John F
authors.initials: JF
authors.lastname: Thompson
mesh_terms: D019788:Fluorodeoxyglucose F18; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D008545:Melanoma / Q000000981:diagnostic imaging* / Q000473:pathology; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D017410:Practice Guidelines as Topic; D011874:Radiometry; D019275:Radiopharmaceuticals; D021701:Sentinel Lymph Node Biopsy; D012867:Skin / Q000000981:diagnostic imaging; D012878:Skin Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18